Meningioma classification by immunohistochemistry: A replicability study

Bibliographic Details
Title: Meningioma classification by immunohistochemistry: A replicability study
Authors: Olivia Näslund, Anna Lipatnikova, Anna Dénes, Cecilia Lindskog, Thomas Olsson Bontell, Anja Smits, Asgeir S. Jakola, Alba Corell
Source: Brain and Spine, Vol 3, Iss , Pp 101711- (2023)
Publisher Information: Elsevier, 2023.
Publication Year: 2023
Collection: LCC:Neurology. Diseases of the nervous system
Subject Terms: Meningioma, Molecular marker, Recurrence, Immunohistochemistry, Neurology. Diseases of the nervous system, RC346-429
More Details: Introduction: Meningiomas account for nearly 40% of intracranial tumors. Recently, the immunohistochemistry (IHC) markers S100B, SCGN, ACADL and MCM2 have been shown to be associated with underlying biological subtypes of meningioma (MG1-MG4). We aimed to evaluate these IHC markers in a clinical setting. Research question: Are the new proposed IHC markers clinically useful? Methods: In total, 244 patients with meningiomas with tissue in TMAs were included and the IHC markers S100B, SCGN, ACADL and MCM2 were analyzed. Two sets of analyses were performed; the first included all samples with any staining considered positive, the second only samples with >10% immunopositivity. PFS and OS were analyzed in correlation to immunopositivity in the second analysis set. Results: In the first set of analyses only 26.2% of samples could be to allocate to one group. No further analyses were performed with this selection. In the second set of analyses 52.0% could be allocated to a group. There was an enrichment of WHO grade 2 and 3 tumors in MG3 and MG4 as compared to MG1 (24.1% and 25.7% vs. 12.1%). Both the molecular group (p ​= ​0.032) and WHO grade (p ​= ​0.005) had significant impact on PFS, but only WHO grade predicted OS (p ​= ​0.033). Conclusion: We studied the proposed new method of classifying meningiomas into groups MG1, MG2, MG3 and MG4 using IHC markers, but found difficulties applying the classification system in our material mainly due to lack of exclusivity of markers. Thus, in its present form the classification method lacks clinical applicability.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2772-5294
Relation: http://www.sciencedirect.com/science/article/pii/S2772529422008529; https://doaj.org/toc/2772-5294
DOI: 10.1016/j.bas.2022.101711
Access URL: https://doaj.org/article/3526948f62164cc3891252fd2ef9d639
Accession Number: edsdoj.3526948f62164cc3891252fd2ef9d639
Database: Directory of Open Access Journals
FullText Links:
  – Type: other
    Url: https://resolver.ebsco.com:443/public/rma-ftfapi/ejs/direct?AccessToken=45609329AD21F2A66494&Show=Object
Text:
  Availability: 0
CustomLinks:
  – Url: https://www.doi.org/10.1016/j.bas.2022.101711?
    Name: ScienceDirect (all content)-s8985755
    Category: fullText
    Text: View record from ScienceDirect
    MouseOverText: View record from ScienceDirect
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=27725294&ISBN=&volume=3&issue=101711-&date=20230101&spage=&pages=&title=Brain and Spine&atitle=Meningioma%20classification%20by%20immunohistochemistry%3A%20A%20replicability%20study&aulast=Olivia%20N%C3%A4slund&id=DOI:10.1016/j.bas.2022.101711
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
  – Url: https://doaj.org/article/3526948f62164cc3891252fd2ef9d639
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from DOAJ
    MouseOverText: View record from DOAJ
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.3526948f62164cc3891252fd2ef9d639
RelevancyScore: 955
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 954.677185058594
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Meningioma classification by immunohistochemistry: A replicability study
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Olivia+Näslund%22">Olivia Näslund</searchLink><br /><searchLink fieldCode="AR" term="%22Anna+Lipatnikova%22">Anna Lipatnikova</searchLink><br /><searchLink fieldCode="AR" term="%22Anna+Dénes%22">Anna Dénes</searchLink><br /><searchLink fieldCode="AR" term="%22Cecilia+Lindskog%22">Cecilia Lindskog</searchLink><br /><searchLink fieldCode="AR" term="%22Thomas+Olsson+Bontell%22">Thomas Olsson Bontell</searchLink><br /><searchLink fieldCode="AR" term="%22Anja+Smits%22">Anja Smits</searchLink><br /><searchLink fieldCode="AR" term="%22Asgeir+S%2E+Jakola%22">Asgeir S. Jakola</searchLink><br /><searchLink fieldCode="AR" term="%22Alba+Corell%22">Alba Corell</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Brain and Spine, Vol 3, Iss , Pp 101711- (2023)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Elsevier, 2023.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2023
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Neurology. Diseases of the nervous system
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Meningioma%22">Meningioma</searchLink><br /><searchLink fieldCode="DE" term="%22Molecular+marker%22">Molecular marker</searchLink><br /><searchLink fieldCode="DE" term="%22Recurrence%22">Recurrence</searchLink><br /><searchLink fieldCode="DE" term="%22Immunohistochemistry%22">Immunohistochemistry</searchLink><br /><searchLink fieldCode="DE" term="%22Neurology%2E+Diseases+of+the+nervous+system%22">Neurology. Diseases of the nervous system</searchLink><br /><searchLink fieldCode="DE" term="%22RC346-429%22">RC346-429</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Introduction: Meningiomas account for nearly 40% of intracranial tumors. Recently, the immunohistochemistry (IHC) markers S100B, SCGN, ACADL and MCM2 have been shown to be associated with underlying biological subtypes of meningioma (MG1-MG4). We aimed to evaluate these IHC markers in a clinical setting. Research question: Are the new proposed IHC markers clinically useful? Methods: In total, 244 patients with meningiomas with tissue in TMAs were included and the IHC markers S100B, SCGN, ACADL and MCM2 were analyzed. Two sets of analyses were performed; the first included all samples with any staining considered positive, the second only samples with >10% immunopositivity. PFS and OS were analyzed in correlation to immunopositivity in the second analysis set. Results: In the first set of analyses only 26.2% of samples could be to allocate to one group. No further analyses were performed with this selection. In the second set of analyses 52.0% could be allocated to a group. There was an enrichment of WHO grade 2 and 3 tumors in MG3 and MG4 as compared to MG1 (24.1% and 25.7% vs. 12.1%). Both the molecular group (p ​= ​0.032) and WHO grade (p ​= ​0.005) had significant impact on PFS, but only WHO grade predicted OS (p ​= ​0.033). Conclusion: We studied the proposed new method of classifying meningiomas into groups MG1, MG2, MG3 and MG4 using IHC markers, but found difficulties applying the classification system in our material mainly due to lack of exclusivity of markers. Thus, in its present form the classification method lacks clinical applicability.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 2772-5294
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: http://www.sciencedirect.com/science/article/pii/S2772529422008529; https://doaj.org/toc/2772-5294
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.1016/j.bas.2022.101711
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/3526948f62164cc3891252fd2ef9d639" linkWindow="_blank">https://doaj.org/article/3526948f62164cc3891252fd2ef9d639</link>
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.3526948f62164cc3891252fd2ef9d639
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.3526948f62164cc3891252fd2ef9d639
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.bas.2022.101711
    Languages:
      – Text: English
    Subjects:
      – SubjectFull: Meningioma
        Type: general
      – SubjectFull: Molecular marker
        Type: general
      – SubjectFull: Recurrence
        Type: general
      – SubjectFull: Immunohistochemistry
        Type: general
      – SubjectFull: Neurology. Diseases of the nervous system
        Type: general
      – SubjectFull: RC346-429
        Type: general
    Titles:
      – TitleFull: Meningioma classification by immunohistochemistry: A replicability study
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Olivia Näslund
      – PersonEntity:
          Name:
            NameFull: Anna Lipatnikova
      – PersonEntity:
          Name:
            NameFull: Anna Dénes
      – PersonEntity:
          Name:
            NameFull: Cecilia Lindskog
      – PersonEntity:
          Name:
            NameFull: Thomas Olsson Bontell
      – PersonEntity:
          Name:
            NameFull: Anja Smits
      – PersonEntity:
          Name:
            NameFull: Asgeir S. Jakola
      – PersonEntity:
          Name:
            NameFull: Alba Corell
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 27725294
          Numbering:
            – Type: volume
              Value: 3
            – Type: issue
              Value: 101711-
          Titles:
            – TitleFull: Brain and Spine
              Type: main
ResultId 1